ORKA

Oruka Therapeutics
ORKA

Upgrade to unlock
Buy
Hold
Sell

3 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$56
63% upside
High target

3 analyst ratings

positive
0  neutral
0%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Wedbush
Wedbush
Martin Fan
100% 1-yr ORKA win rate
13 Jan ‘26 1 month ago
BTIG
BTIG
Julian Harrison
75% 1-yr ORKA win rate
12 Jan ‘26 1 month ago
UBS
UBS
Michael Yee
100% 1-yr ORKA win rate
7 Jan ‘26 1 month ago
Piper Sandler
Piper Sandler
Yasmeen Rahimi
0% 1-yr ORKA win rate
18 Dec ‘25 2 months ago